Filing Details

Accession Number:
0001144204-10-030800
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-27 13:00:00
Reporting Period:
2010-05-25
Filing Date:
2010-05-27
Accepted Time:
2010-05-27 19:30:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124608 Response Genetics Inc RGDX In Vitro & In Vivo Diagnostic Substances (2835) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1401803 Kathleen Danenberg C/O Response Genetics, Inc.
1640 Marengo St., 6Th Floor
Los Angeles CA 90033
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Acquisiton 2010-05-25 2,600 $2.22 428,708 No 4 P Direct
Common Stock, Par Value $0.01 Acquisiton 2010-05-26 1,700 $2.30 430,408 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Consists of 426,108 shares of common stock jointly owned by the reporting filer and her husband, Peter Danenberg.